Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ceva Santé Animale is a leading global veterinary pharmaceutical company specializing in the research, development, production, and marketing of pharmaceutical products and vaccines for livestock and companion animals. The company's poultry division is a global leader in hatchery technologies and avian vaccinology, particularly known for its innovative vector vaccine range, Vectormune, and immune-complex technology, Transmune. Ceva provides integrated health solutions that include automated vaccination equipment (Ceva-Desvac) and diagnostic services to optimize flock health and productivity. Headquartered in France, the company operates in over 110 countries with a strong commitment to preventive medicine and the One Health approach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ceva Poultry.